Entasis Therapeutics to Present on ETX2514SUL at IDWeek 2018
October 03, 2018 08:00 ET
|
Entasis Therapeutics Holdings Inc.
WALTHAM, Mass., Oct. 03, 2018 (GLOBE NEWSWIRE) -- Entasis Therapeutics (NASDAQ: ETTX), a clinical-stage biopharmaceutical company focused on the discovery and development of novel antibacterial...
Entasis Therapeutics Announces Pricing of Initial Public Offering
September 25, 2018 21:55 ET
|
Entasis Therapeutics Holdings Inc.
WALTHAM, Mass., Sept. 25, 2018 (GLOBE NEWSWIRE) -- Entasis Therapeutics Holdings Inc. (Nasdaq: ETTX), a clinical-stage biopharmaceutical company focused on the discovery and development of novel...